Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“However, we experienced a case with recurrent VF associated with ERS refractory to a small dose of quinidine , which was prevented by the oral administration of cilostazol , an oral phosphodiesterase III inhibitor.”
“Addition of the transient outward current antagonist quinidine (5 &mgr;mol/L) or the phosphodiesterase III inhibitors cilostazol (10 &mgr;mol/L) or milrinone (5 &mgr;mol/L) diminished the ER manifestations and prevented the hypothermia-induced phase 2 reentry and VT/VF.”